GSK (NYSE: GSK) chief people officer acquires ADS via pension plan

Rhea-AI Filing Summary

GSK plc reported that its Chief People Officer, Diana Conrad, acquired American Depositary Shares (ADS) under a GSK pension plan. She acquired 428.137 ADS at $52.0278 per ADS on 2026-03-24 and 12.186 ADS at $54.4682 per ADS on 2026-03-30 on the New York Stock Exchange.

Key Figures

ADS acquired: 428.137 ADS ADS price: $52.0278 per ADS ADS acquired: 12.186 ADS +1 more

4 metrics

ADS acquired 428.137 ADS Acquisition under GSK pension plan on 2026-03-24

ADS price $52.0278 per ADS Price for 428.137 ADS on 2026-03-24

ADS acquired 12.186 ADS Acquisition under GSK pension plan on 2026-03-30

ADS price $54.4682 per ADS Price for 12.186 ADS on 2026-03-30

Key Terms

American Depositary Shares, ADS, pension plan, PDMR, +1 more

5 terms

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

ADS financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

Ads are paid promotional messages a company places across media — online, on TV, in print, or on social platforms — to attract customers, explain products, or shape public perception. For investors, ads matter because they drive sales growth, affect how much a company must spend to win customers, and influence brand strength and long-term value. Ads can also create regulatory or reputational risk if claims are misleading, which can affect profits and stock price.

pension plan financial

"Nature of the transaction | Acquisition of ADS under GSK pension plan"

A pension plan is a long-term program set up to pay retirees a regular income after they stop working, funded by employers, employees, or both. For investors, pension plans matter because they represent large pools of invested money that can move markets, create long-term demand for assets, and pose financial risks if promised payments exceed available funds — think of it as a community savings pot that must be managed carefully to meet future bills.

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

LEI regulatory

"Details of the issuer ... b) | LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

​

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Diana Conrad
b)	Position/status	Chief People Officer
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ​ ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of ADS under GSK pension plan
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$52.0278	428.137
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2026-03-24
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Diana Conrad
b)	Position/status	Chief People Officer
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ​ ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of ADS under GSK pension plan
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$54.4682	12.186
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2026-03-30
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: April 01, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What did GSK (GSK) disclose in this Form 6-K filing?

GSK disclosed that Chief People Officer Diana Conrad acquired American Depositary Shares under a GSK pension plan. The filing details two small ADS purchases on the New York Stock Exchange, including exact prices, volumes, and transaction dates in March 2026.

Who is Diana Conrad in relation to GSK (GSK)?

Diana Conrad is GSK’s Chief People Officer and is treated as a person discharging managerial responsibilities. The Form 6-K reports her acquisitions of GSK American Depositary Shares under a company pension plan, including transaction dates, prices, and volumes on the New York Stock Exchange.

How many GSK (GSK) ADS did Diana Conrad acquire on 2026-03-24?

On 2026-03-24, Diana Conrad acquired 428.137 GSK American Depositary Shares at a price of $52.0278 per ADS. The transaction was carried out under a GSK pension plan and took place on the New York Stock Exchange, as disclosed in the Form 6-K.

What was the second ADS transaction reported for GSK (GSK)?

The second reported transaction shows Diana Conrad acquiring 12.186 American Depositary Shares on 2026-03-30 at $54.4682 per ADS. This purchase was also made under the GSK pension plan on the New York Stock Exchange, and is listed as a single aggregated transaction.

On which exchange were the reported GSK (GSK) ADS transactions executed?

Both reported GSK American Depositary Share transactions were executed on the New York Stock Exchange, identified as XNYS. The filing specifies this venue for the March 24 and March 30, 2026 acquisitions under the GSK pension plan by Chief People Officer Diana Conrad.

What type of instrument did GSK (GSK) report in this filing?

The filing reports transactions in GSK American Depositary Shares, described as ADS with ISIN US37733W2044. These ADS represent the company’s equity for trading in the United States and were acquired under a GSK pension plan on specific dates in March 2026.